{
    "id": 1119,
    "fullName": "RAF1 S259A",
    "impact": "missense",
    "proteinEffect": "gain of function",
    "geneVariantDescriptions": [
        {
            "description": "RAF1 S259A lies within the CR2 domain of the Raf1 protein (PMID: 17603482). S259A confers a gain of function as demonstrated by the induction of anchorage-independent growth and increased MEK/ERK phosphorylation as compared to wild-type Raf1 in culture (PMID: 24569458).",
            "references": [
                {
                    "id": 494,
                    "pubMedId": 17603482,
                    "title": "Germline gain-of-function mutations in RAF1 cause Noonan syndrome.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/17603482"
                },
                {
                    "id": 251,
                    "pubMedId": 24569458,
                    "title": "Oncogenic and sorafenib-sensitive ARAF mutations in lung adenocarcinoma.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/24569458"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 5894,
        "geneSymbol": "RAF1",
        "terms": [
            "RAF1",
            "c-Raf",
            "CMD1NN",
            "CRAF",
            "NS5",
            "Raf-1"
        ]
    },
    "variant": "S259A",
    "createDate": "07/23/2014",
    "updateDate": "07/22/2019",
    "referenceTranscriptCoordinates": {
        "id": 161949,
        "transcript": "NM_002880",
        "gDna": "chr3:g.12604195A>C",
        "cDna": "c.775T>G",
        "protein": "p.S259A",
        "sourceDb": "RefSeq",
        "refGenomeBuild": "GRCh38/hg38"
    },
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 2174,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, a transformed human lung epithelial cell line expressing RAF1 S259A demonstrated sensitivity to Nexavar (sorafenib) resulting in decreased phosphorylation of MEK in culture (PMID: 24569458).",
            "molecularProfile": {
                "id": 1158,
                "profileName": "RAF1 S259A"
            },
            "therapy": {
                "id": 920,
                "therapyName": "Sorafenib",
                "synonyms": null
            },
            "indication": {
                "id": 1324,
                "name": "lung cancer",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 251,
                    "pubMedId": 24569458,
                    "title": "Oncogenic and sorafenib-sensitive ARAF mutations in lung adenocarcinoma.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/24569458"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 2175,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, a transformed human lung epithelial cell line expressing RAF1 S259A demonstrated sensitivity to Mekinist (trametinib) resulting in decreased phosphorylation of Erk in culture (PMID: 24569458).",
            "molecularProfile": {
                "id": 1158,
                "profileName": "RAF1 S259A"
            },
            "therapy": {
                "id": 2,
                "therapyName": "Trametinib",
                "synonyms": null
            },
            "indication": {
                "id": 1324,
                "name": "lung cancer",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 251,
                    "pubMedId": 24569458,
                    "title": "Oncogenic and sorafenib-sensitive ARAF mutations in lung adenocarcinoma.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/24569458"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 1158,
            "profileName": "RAF1 S259A",
            "profileTreatmentApproaches": [
                {
                    "id": 5173,
                    "name": "Trametinib",
                    "profileName": "RAF1 S259A"
                },
                {
                    "id": 5172,
                    "name": "RAF Inhibitor (Pan)",
                    "profileName": "RAF1 S259A"
                }
            ]
        }
    ],
    "allTranscriptCoordinates": [
        {
            "id": 161951,
            "transcript": "XM_005265355",
            "gDna": "chr3:g.12604195A>C",
            "cDna": "c.775T>G",
            "protein": "p.S259A",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 161949,
            "transcript": "NM_002880",
            "gDna": "chr3:g.12604195A>C",
            "cDna": "c.775T>G",
            "protein": "p.S259A",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 161950,
            "transcript": "XM_011533974",
            "gDna": "chr3:g.12604195A>C",
            "cDna": "c.775T>G",
            "protein": "p.S259A",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        }
    ]
}